[1]
S. Maneesuwansin, “Administration of Renin-Angiotensin System Inhibitor Affects Tumor Recurrence and Progression in Non-Muscle Invasive Bladder Cancer Patients”, Siriraj Med J, vol. 71, no. 1, pp. 31–37, Feb. 2019.